BETTI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.287
EU - Europa 782
AS - Asia 300
OC - Oceania 14
AF - Africa 4
Totale 2.387
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.285
RU - Federazione Russa 226
PL - Polonia 165
IT - Italia 124
IE - Irlanda 123
VN - Vietnam 76
SE - Svezia 73
CN - Cina 59
SG - Singapore 56
HK - Hong Kong 39
IN - India 29
ES - Italia 18
FI - Finlandia 16
DE - Germania 15
AU - Australia 14
JO - Giordania 11
JP - Giappone 11
GB - Regno Unito 9
ID - Indonesia 8
BE - Belgio 4
CI - Costa d'Avorio 4
IQ - Iraq 3
NL - Olanda 3
TR - Turchia 3
TW - Taiwan 3
CA - Canada 2
EE - Estonia 2
UA - Ucraina 2
FR - Francia 1
IL - Israele 1
KR - Corea 1
LT - Lituania 1
Totale 2.387
Salva come PNG Salva come JPEG
Città #
Santa Clara 436
Warsaw 164
Chandler 123
Dublin 123
Fairfield 100
Ashburn 87
Dong Ket 76
Houston 50
Woodbridge 49
Seattle 47
Singapore 47
Wilmington 45
Cambridge 42
Florence 37
Ann Arbor 31
Princeton 25
Hong Kong 24
Beijing 22
Mumbai 18
Barcelona 17
Altamura 16
Shanghai 15
Lawrence 13
Melbourne 13
Boston 12
Medford 11
New York 10
Jakarta 8
Cagliari 7
Munich 7
Helsinki 6
Kent 6
Boardman 5
Gavirate 5
Ponte 5
Abidjan 4
Brussels 4
Hyderabad 4
Tokyo 4
West Jordan 4
Buffalo 3
Falls Church 3
San Diego 3
Hefei 2
London 2
Los Angeles 2
Markham 2
Nagoya 2
Norwalk 2
Padova 2
Parma 2
Pune 2
Romola 2
San Jose 2
Surat 2
Taichung 2
Tallinn 2
Trumbull 2
Augusta 1
Barnaul 1
Böblingen 1
Cantagallo 1
Castelfranco di Sotto 1
Chongqing 1
Chuxiong 1
Cortona 1
Ferrara 1
Glasgow 1
Guangzhou 1
Hebei 1
Hillsboro 1
Istanbul 1
Jacksonville 1
Kunming 1
Lappeenranta 1
Madrid 1
Massa 1
Misano Adriatico 1
Moscow 1
Palo Alto 1
Polska 1
Pontassieve 1
Poulsbo 1
Prato 1
Quanzhou 1
Rignano Sull'arno 1
Rome 1
Rotterdam 1
Rui'an 1
Salerno 1
Sant'elpidio A Mare 1
Seoul 1
Sesto Fiorentino 1
Shaoxing 1
Stockholm 1
Taipei 1
Tel Aviv 1
Terracina 1
Upland 1
Washington 1
Totale 1.803
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and pharmacological evaluation of new adenosine receptor ligands 320
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 217
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 165
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 143
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 128
Design, synthesis, and pharmacological characterization of 2‑(2- furanyl)thiazolo[5,4‑d]pyrimidine-5,7-diamine derivatives: new highly potent A2A adenosine receptor inverse agonists with antinociceptive activity 127
1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure–affinity relationships and molecular modeling studies 120
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 116
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A1 and A2A adenosine receptors. Molecular modeling and pharmacological studies 115
Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation 108
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2Breceptor 107
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 98
2-Aryl-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as new potent adenosine human A2A receptor antagonists 97
null 90
Thiazolo[5,4-d]pyrimidin-7-amino derivatives as dual human adenosine A2A/A1 receptor antagonists. 87
New aminopyridine-3,5-dicarbonitirles as adenosine A2B receptor non-nucleoside agonists. 86
Aminopyridine-3,5-carbonitrile core for the design of new adenosine receptor agonists: structural exploration to target the A1 subtype 85
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new potent and selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. 81
New 5-heteroaryl-pyrazolo[4,3-d]pyrimidin-7-amines as dual human adenosine A1 and A2A receptor antagonists. 80
Aminopyridine-3,5-dicarbonitriles as non-nucleoside adenosine A1 receptor agonists. 70
Totale 2.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.551
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020136 0 0 0 0 0 0 27 31 23 24 25 6
2020/2021253 9 27 1 30 11 6 4 13 23 36 15 78
2021/2022137 4 10 17 5 3 8 3 6 7 9 23 42
2022/2023416 34 71 33 31 32 73 47 40 42 0 9 4
2023/2024196 3 17 18 5 5 69 4 43 10 7 9 6
2024/2025897 26 131 75 135 356 172 2 0 0 0 0 0
Totale 2.440